Cargando…

Molecular Profiling in Non-Squamous Non-Small Cell Lung Carcinoma: Towards a Switch to Next-Generation Sequencing Reflex Testing

Molecular diagnosis of lung cancer is a constantly evolving field thanks to major advances in precision oncology. The wide range of actionable molecular alterations in non-squamous non-small cell lung carcinoma (NS-NSCLC) and the multiplicity of mechanisms of resistance to treatment resulted in the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pujol, Nina, Heeke, Simon, Bontoux, Christophe, Boutros, Jacques, Ilié, Marius, Hofman, Véronique, Marquette, Charles-Hugo, Hofman, Paul, Benzaquen, Jonathan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9605324/ https://www.ncbi.nlm.nih.gov/pubmed/36294823 http://dx.doi.org/10.3390/jpm12101684

Ejemplares similares

Setting Up an Ultra-Fast Next-Generation Sequencing Approach as Reflex Testing at Diagnosis of Non-Squamous Non-Small Cell Lung Cancer; Experience of a Single Center (LPCE, Nice, France)
por: Ilié, Marius, et al.
Publicado: (2022)

Deciphering the Impact of HER2 Alterations on Non-Small-Cell Lung Cancer: From Biological Mechanisms to Therapeutic Approaches
por: Bontoux, Christophe, et al.
Publicado: (2022)

Targeted Assessment of the EGFR Status as Reflex Testing in Treatment-Naive Non-Squamous Cell Lung Carcinoma Patients: A Single Laboratory Experience (LPCE, Nice, France)
por: Lassalle, Sandra, et al.
Publicado: (2020)

Prospective evaluation of NGS-based liquid biopsy in untreated late stage non-squamous lung carcinoma in a single institution
por: Heeke, Simon, et al.
Publicado: (2020)

Circulating Tumor Cell Detection in Lung Cancer: But to What End?
por: Hofman, Véronique, et al.
Publicado: (2019)

A Real-World Experience from a Single Center (LPCE, Nice, France) Highlights the Urgent Need to Abandon Immunohistochemistry for ROS1 Rearrangement Screening of Advanced Non-Squamous Non-Small Cell Lung Cancer
por: Hofman, Véronique, et al.
Publicado: (2023)

Accurate Detection of SARS-CoV-2 by Next-Generation Sequencing in Low Viral Load Specimens
por: Ilié, Marius, et al.
Publicado: (2023)

Identification of a circulating immunological signature predictive of response to immune checkpoint inhibitors in patients with advanced non‐small cell lung cancer
por: Khatir, Wassila, et al.
Publicado: (2022)

Setting-Up a Rapid SARS-CoV-2 Genome Assessment by Next-Generation Sequencing in an Academic Hospital Center (LPCE, Louis Pasteur Hospital, Nice, France)
por: Hofman, Paul, et al.
Publicado: (2022)

Detection of EGFR Mutations From Plasma of NSCLC Patients Using an Automatic Cartridge-Based PCR System
por: Heeke, Simon, et al.
Publicado: (2021)

Deep Learning Facilitates Distinguishing Histologic Subtypes of Pulmonary Neuroendocrine Tumors on Digital Whole-Slide Images
por: Ilié, Marius, et al.
Publicado: (2022)

Lung Cancer Screening, towards a Multidimensional Approach: Why and How?
por: Benzaquen, Jonathan, et al.
Publicado: (2019)

Detection of ALK fusion transcripts in plasma of non-small cell lung cancer patients using a novel RT-PCR based assay
por: Heeke, Simon, et al.
Publicado: (2021)

Daily Practice Assessment of KRAS Status in NSCLC Patients: A New Challenge for the Thoracic Pathologist Is Right around the Corner
por: Bontoux, Christophe, et al.
Publicado: (2022)

Escape of SARS-CoV-2 Variant Omicron to Mucosal Immunity in Vaccinated Subjects
por: Martinuzzi, Emanuela, et al.
Publicado: (2022)

Use of the Ion PGM and the GeneReader NGS Systems in Daily Routine Practice for Advanced Lung Adenocarcinoma Patients: A Practical Point of View Reporting a Comparative Study and Assessment of 90 Patients
por: Heeke, Simon, et al.
Publicado: (2018)

Evaluation of Sample Pooling for SARS-CoV-2 Detection in Nasopharyngeal Swab and Saliva Samples with the Idylla SARS-CoV-2 Test
por: Hofman, Paul, et al.
Publicado: (2021)

In-House Implementation of Tumor Mutational Burden Testing to Predict Durable Clinical Benefit in Non-Small Cell Lung Cancer and Melanoma Patients
por: Heeke, Simon, et al.
Publicado: (2019)

A case report of exogenous lipoid pneumonia associated with avocado/soybean unsaponifiables
por: BOUTROS, Jacques, et al.
Publicado: (2019)

Alternative splicing of P2RX7 pre-messenger RNA in health and diseases: Myth or reality?
por: Benzaquen, Jonathan, et al.
Publicado: (2019)

Ultrafast Gene Fusion Assessment for Nonsquamous NSCLC
por: Hofman, Véronique, et al.
Publicado: (2022)

Optimization of EGFR mutation detection by the fully-automated qPCR-based Idylla system on tumor tissue from patients with non-small cell lung cancer
por: Ilie, Marius, et al.
Publicado: (2017)

Mutations in KMT2C, BCOR and KDM5C Predict Response to Immune Checkpoint Blockade Therapy in Non-Small Cell Lung Cancer
por: Liu, Dingxie, et al.
Publicado: (2022)

Salivary detection of COVID-19: clinical performance of oral sponge sampling for SARS-CoV-2 testing
por: Boutros, Jacques, et al.
Publicado: (2021)

Circulating tumour cells as a potential screening tool for lung cancer (the AIR study): protocol of a prospective multicentre cohort study in France
por: Leroy, Sylvie, et al.
Publicado: (2017)

Two Panels of Plasma MicroRNAs as Non-Invasive Biomarkers for Prediction of Recurrence in Resectable NSCLC
por: Sanfiorenzo, Céline, et al.
Publicado: (2013)

Multidisciplinary management of tracheobronchial injury
por: Boutros, Jacques, et al.
Publicado: (2022)

The Need to Set up a Biobank Dedicated to Lymphoid Malignancies: Experience of a Single Center (Laboratory of Clinical and Experimental Pathology, University Côte d’Azur, Nice, France)
por: Bontoux, Christophe, et al.
Publicado: (2023)

The Third Joint Meeting on Lung Cancer of the FHU OncoAge (University Côte d’Azur, Nice, France) and the University of Texas MD Anderson Cancer Center (Houston, TX, USA). Understanding New Therapeutic Options and Promising Predictive Biomarkers for Lung Cancer Patients
por: Hofman, Paul, et al.
Publicado: (2022)

Prognostic Role of KRAS G12C Mutation in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
por: Wankhede, Durgesh, et al.
Publicado: (2023)

“Sentinel” Circulating Tumor Cells Allow Early Diagnosis of Lung Cancer in Patients with Chronic Obstructive Pulmonary Disease
por: Ilie, Marius, et al.
Publicado: (2014)

P2RX7B is a new theranostic marker for lung adenocarcinoma patients
por: Benzaquen, Jonathan, et al.
Publicado: (2020)

The Importance of STK11/LKB1 Assessment in Non-Small Cell Lung Carcinomas
por: Mograbi, Baharia, et al.
Publicado: (2021)

Any Place for Immunohistochemistry within the Predictive Biomarkers of Treatment in Lung Cancer Patients?
por: Hofman, Véronique, et al.
Publicado: (2018)

A rapid near-patient RT-PCR test for suspected COVID-19: a study of the diagnostic accuracy
por: Hofman, Paul, et al.
Publicado: (2021)

Clinical value of circulating endothelial cells and of soluble CD146 levels in patients undergoing surgery for non-small cell lung cancer
por: Ilie, M, et al.
Publicado: (2014)

The Purinergic Landscape of Non-Small Cell Lung Cancer
por: Janho dit Hreich, Serena, et al.
Publicado: (2022)

Expression of MET in circulating tumor cells correlates with expression in tumor tissue from advanced-stage lung cancer patients
por: Ilie, Marius, et al.
Publicado: (2017)

Establishing a Dedicated Lung Cancer Biobank at the University Center Hospital of Nice (France). Why and How?
por: Washetine, Kevin, et al.
Publicado: (2018)

Setting up a wide panel of patient-derived tumor xenografts of non–small cell lung cancer by improving the preanalytical steps
por: Ilie, Marius, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_sk8hbftp7h0pbfoeu8hcl3vecb